Review Papers Claim by Claim

Visualized structural conclusions (what the maps show)

1. sfCHT adopts a 14-TM LeuT-fold architecture; cryo-EM Na+-bound map at 2.83 Å (PDB 9RWT / EMD-54347) and choline-bound map at 3.28 Å (PDB 9RWS / EMD-54346) were built de novo and refined (sfCHT structural data).
2. Inward-facing conformation with Na+ coordinated near the unwound TM3/TM8 region; choline density is absent from canonical central site but present at a cytoplasmic vestibule close to residues Q303/R304/R84/S307 — interpreted as a pre-release intermediate (sfCHT cytoplasmic site).

Mechanistic model (evidence chain)

• PELE unsupervised docking + induced-fit runs map low-energy choline poses from the central canonical site to the cytoplasmic vestibule; predicted intermediates reposition key aromatics (W99/W176/W298/W445) and polar gating residues (Q303/R304/R84) (PELE pathway analysis).
• Transport assays: proteoliposomes with purified sfCHT show Na+-dependent 3H-choline uptake blocked by hemicholinium-3; alanine substitutions at Q303, R304, R84 strongly reduce uptake; corresponding CHT1 (human) substitutions produce concordant functional losses or Vmax changes, supporting conservation (Functional mutagenesis & kinetics).

Critical appraisal — strengths and limitations

Strengths (well-supported):

• High-resolution cryo-EM with deposited maps/models (PDB 9RWT/9RWS; EMDB EMD-54347/54346) enabling atomic assignment of ions and ligand density (Data deposition & methods).
• Orthogonal validation: computational PELE paths and experimental mutagenesis in two systems (bacterial sfCHT and human CHT1) produce concordant functional effects — increases confidence in conserved roles of identified residues.

Limitations / Blindspots (caveats that moderate claims):

• Detergent environment: structures were solved in DDM micelles; detergent can bias conformational distributions, especially for small, dynamic transporters — the canonical central binding site was empty in sfCHT inward maps while CHT1 (in other studies) captured substrate there; potential stabilization of inward-open state by DDM is plausible and acknowledged by authors (Detergent-state caveat).
• Missing anion (Cl-): human CHT1 structures show a Cl- within the central cavity that helps substrate coordination; sfCHT maps lack that ion which could alter binding geometry and energetics — limits direct structural parity with CHT1 (CHT1 chloride & binding).
• Dynamics inferred via PELE: PELE provides plausible low-energy ligand paths but is not a full dynamical MD sampling of an explicit membrane/ion environment; free-energy barriers and kinetics require complementary explicit MD/PMF calculations for quantitative rates.
• Generality across bacteria: sfCHT is one prokaryotic ortholog; authors presented sequence similarity across some bacterial homologs but biological roles/physiological contexts in other bacteria remain untested experimentally.

How convincing is the conservation claim?

Evidence in favor: (i) structural LeuT-fold and Na+ position concordant with CHT1; (ii) matching functional effects of orthologous substitutions (sfCHT ↔ CHT1) altering uptake or Vmax; (iii) PELE-predicted transition states consistent with mutagenesis.

Remaining uncertainty: absence of choline in the canonical central pocket in sfCHT maps (unlike some CHT1 structures) and missing Cl- leave open whether the full sequence of ligand/ion-coupled conformational transitions are identical between sfCHT and human CHT1. Independent membrane-reconstituted structural studies (nanodiscs or lipid vesicles), or MD/PMF in explicit membranes with ions, would strengthen the evolutionary-conservation claim.

Concrete, falsifiable tests that would overturn key conclusions

1. Show that alanine substitutions at Q303/R304/R84 in native membrane (e.g., sfCHT reconstituted in lipid nanodiscs or in bacteria) produce no change in transport — that would falsify their proposed gating role.
2. Obtain sfCHT structures in lipid nanodiscs with physiological Cl- and choline and demonstrate choline occupies a different central pose (not requiring the cytoplasmic site) — that would challenge the pre-release-site interpretation as obligatory for translocation.
3. Perform explicit membrane MD + umbrella-sampling PMF to quantify barriers along the predicted PELE path; if barriers are inconsistent with observed kinetics, PELE-based pathway would be questioned.

Practical takeaways & next experiments (concise)

• Repeat cryo-EM in lipid nanodiscs with physiologic Cl- to capture outward, occluded, and inward states—compare to CHT1 chloride-containing structures (CHT1 structural benchmarks).
• Explicit MD + PMF to compute energetics for choline migration along PELE-identified route (quantify barriers, ion-coupling contributions).
• Assess bacterial physiological role: knock-out/knock-in of sfCHT orthologs in native strains and fitness under osmotic stress / choline-limited growth to link structure→function→biology.